latest news releases from the newsroom
Mariner's Choice International, Inc.
Mariner's Choice CEO Issues Shareholder Letter
JACKSONVILLE, Fla., March 6, 2008 (PRIME NEWSWIRE) -- Mariner's Choice International Inc. (Pink Sheets:MCII) CEO Amie Hingston issued a letter to shareholders recapping the activities and developments of 2007 and outlining elements of its growth strategy for 2008.
Frequency Electronics, Inc.
Frequency Electronics Announces Earnings Conference Call; Monday, March 10, 2008, at 1:00 PM ET
MITCHEL FIELD, N.Y., March 6, 2008 (PRIME NEWSWIRE) -- Frequency Electronics, Inc. (Nasdaq:FEIM) will hold its quarterly conference call to discuss results for the third quarter of fiscal year 2008, ended January 31, 2008, on Monday, March 10, 2008, at 1:00 PM Eastern Time.
Protea Biosciences, Inc.
Protea Launches New Proteomics Service
MORGANTOWN, W.Va., March 6, 2008 (PRIME NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new protein processing technology, today announced its launch of a new service for rapid protein identification. Known as "gelSTAT," the new service provides complete results within five working days, unprecedented turnaround time for protein mass spectrometry analysis.
ContextWeb Names Interpublic, Kelly Blue Book and CBS Digital Veterans to New Board of Advisors
NEW YORK, March 6, 2008 (PRIME NEWSWIRE) -- ContextWeb, Inc., a leading contextual advertising company, today announced the establishment of the ContextWeb Advisory Board. Joining the new board are Ira Carlin, former Chairman-International of Interpublic's MAGNA Global Worldwide and former Chairman of Universal McCann; Robin Cooper, Vice President of Advertising and Business Development for auto publisher Kelley Blue Book; and Scot McLernon, President of the Upstream Group, Inc. and former head of sales for CBS Digital.
Znomics Appoints Stephane Berghmans, D.V.M., Ph.D. to Director of Drug Discovery
PORTLAND, Ore., March 6, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the appointment of Stephane Berghmans, D.V.M., Ph.D. to Director of Drug Discovery, effective March 10, 2008.